These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 8788432

  • 41. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
    Imam MZ, Kuo A, Ghassabian S, Cai Y, Qin Y, Li T, Smith MT.
    Eur J Pharmacol; 2020 Mar 15; 871():172918. PubMed ID: 31958457
    [Abstract] [Full Text] [Related]

  • 42. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK, Ford BM, Ketkar A, Wan A, Penthala NR, Eoff RL, Prather PL, Dobretsov M, Crooks PA.
    Pharmacol Res; 2016 Nov 15; 113(Pt A):335-347. PubMed ID: 27637375
    [Abstract] [Full Text] [Related]

  • 43. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R, Niizawa S, Koike K, Sagara T, Kanematsu K, Takayanagi I.
    Arch Int Pharmacodyn Ther; 1996 Nov 15; 331(2):136-52. PubMed ID: 8937625
    [Abstract] [Full Text] [Related]

  • 44. Behavioral effects and binding affinities of the fentanyl derivative OHM3507.
    France CP, Ahn SC, Brockunier LL, Bagley JR, Brandt MR, Winsauer PJ, Moerschbaecher JM.
    Pharmacol Biochem Behav; 1998 Feb 15; 59(2):295-303. PubMed ID: 9476973
    [Abstract] [Full Text] [Related]

  • 45. Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays.
    Márki A, Monory K, Otvös F, Tóth G, Krassnig R, Schmidhammer H, Traynor JR, Roques BP, Maldonado R, Borsodi A.
    Eur J Pharmacol; 1999 Oct 27; 383(2):209-14. PubMed ID: 10585536
    [Abstract] [Full Text] [Related]

  • 46. Opioid receptor affinity and analgesic activity of O- and C-glycosylated opioid peptides.
    Negri L, Melchiorri P, Rocchi R, Scolaro B.
    Acta Physiol Hung; 1996 Oct 27; 84(4):441-3. PubMed ID: 9328626
    [Abstract] [Full Text] [Related]

  • 47. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB.
    J Med Chem; 1998 Jul 16; 41(15):2872-81. PubMed ID: 9667975
    [Abstract] [Full Text] [Related]

  • 48. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.
    J Pharmacol Exp Ther; 2003 Dec 16; 307(3):1135-41. PubMed ID: 14557378
    [Abstract] [Full Text] [Related]

  • 49. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ, Takemori AE.
    J Pharmacol Exp Ther; 1983 Mar 16; 224(3):525-30. PubMed ID: 6131119
    [Abstract] [Full Text] [Related]

  • 50. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY, Zhao M, Yuan YK, Fan GX, Jia H, Tang JS.
    Neuroscience; 2006 Mar 16; 138(4):1319-27. PubMed ID: 16472929
    [Abstract] [Full Text] [Related]

  • 51. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R, Auerbach SB.
    J Pharmacol Exp Ther; 2002 Nov 16; 303(2):549-56. PubMed ID: 12388635
    [Abstract] [Full Text] [Related]

  • 52. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD, Bayer BM.
    Brain Res; 1998 Apr 06; 789(1):56-67. PubMed ID: 9602057
    [Abstract] [Full Text] [Related]

  • 53. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M, Mizoguchi H, Kampine JP, Tseng LF.
    Br J Pharmacol; 1996 Aug 06; 118(7):1829-35. PubMed ID: 8842450
    [Abstract] [Full Text] [Related]

  • 54. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K, Varga EV, Alfaro-Lopez J, Tang X, Vanderah TW, Porreca F, Hruby VJ, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 2003 Feb 06; 304(2):683-8. PubMed ID: 12538822
    [Abstract] [Full Text] [Related]

  • 55. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D, Watanabe C, Watanabe H, Mizoguchi H, Sakurada T, Sakurada S.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):109-16. PubMed ID: 17343845
    [Abstract] [Full Text] [Related]

  • 56. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
    Ananthan S, Khare NK, Saini SK, Davis P, Dersch CM, Porreca F, Rothman RB.
    Bioorg Med Chem; 2003 Sep 01; 11(18):4143-54. PubMed ID: 12927876
    [Abstract] [Full Text] [Related]

  • 57. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
    Bhalla S, Zhang Z, Patterson N, Gulati A.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):62-71. PubMed ID: 20303944
    [Abstract] [Full Text] [Related]

  • 58. Increase of nitric oxide by L-arginine potentiates beta-endorphin- but not mu-, delta- or kappa-opioid agonist-induced antinociception in the mouse.
    Xu JY, Tseng LF.
    Eur J Pharmacol; 1993 May 12; 236(1):137-42. PubMed ID: 8391452
    [Abstract] [Full Text] [Related]

  • 59. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
    Qi JA, Bowen WD, Mosberg HI, Rothman RB, Porreca F.
    J Pharmacol Exp Ther; 1990 Nov 12; 255(2):636-41. PubMed ID: 2173752
    [Abstract] [Full Text] [Related]

  • 60. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 12; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.